✦ LIBER ✦

Treatment of patients with genotype 3 chronic hepatitis C- current and future therapies

✍ Scribed by Shiv K. Sarin; Chandan K. N. Kumar

Book ID: 111239682
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 121 KB
Volume: 32
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2011.02715.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of autoimmune hepatitis: Curre

Treatment of autoimmune hepatitis: Current and future therapies

✍ Fernando Alvarez 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 330 KB

Response-guided therapy in patients with

Response-guided therapy in patients with genotype 1 hepatitis C virus: Current status and future prospects

✍ Lawitz, Eric J; Membreno, Fernando E 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

The future for the treatment of genotype

The future for the treatment of genotype 4 chronic hepatitis C

✍ G. Esmat; M. El Raziky; M. El Kassas; M. Hassany; M.E. Gamil 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Treatment of Chronic Hepatitis C, Genoty

Treatment of Chronic Hepatitis C, Genotype 4

✍ Ferenci, Peter 📂 Article 📅 2013 🏛 Current Science Inc. 🌐 English ⚖ 137 KB

Treatment of patients infected with chro

Treatment of patients infected with chronic hepatitis C genotype 2 and 3: More data, more questions?

✍ Ivo W. Graziadei; Wolfgang Vogel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

Chronic hepatitis C genotype 2 or 3 shor

Chronic hepatitis C genotype 2 or 3 short treatment

✍ Ricardo Moreno-Otero; María Trapero; José A. Moreno-Monteagudo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

Dalgard et al. 1 reported interesting data on 14 versus 24 weeks of combination therapy in patients with hepatitis C virus (HCV) genotype 2 or 3, and they concluded that it is rational to treat those patients with rapid virological response (RVR) for only 14 weeks. Adequate treatment duration is gen